X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/epivax-licenses-ispri-toolkit-to-eisai-for-preclinical-in-silico-immunogenicity-screening-302020194.html
https://www.prnewswire.com/news-releases/epivax-and-zoetis-to-collaborate-on-swine-t-cell-epitope-prediction-tool-circomatch-301715606.html
https://www.globenewswire.com/news-release/2023/01/09/2585082/0/en/GreenLight-Biosciences-and-Epivax-Therapeutics-Sign-Exclusive-Collaboration-Agreement-to-Develop-Personalized-Cancer-Vaccines.html
https://www.prnewswire.com/news-releases/epivax-secures-additional-funding-from-fda-for-immunogenicity-risk-assessment-for-biosimilar-products-301621585.html
https://www.prnewswire.com/news-releases/epivax-collaborates-with-leidos-on-malaria-vaccine-research-series-of-papers-published-in-frontiers-of-immunology-301426218.html
https://www.prnewswire.com/news-releases/epivax-identifies-t-cell-epitopes-critical-to-robust-t-cell-immune-response-in-sars-cov-2--results-published-in-npj-vaccines-301292513.html
https://www.biospace.com/article/releases/epivax-and-epivax-therapeutics-advance-covid-19-vaccine-program-epv-cov-19/
https://www.prnewswire.com/news-releases/epivax-advances-panda-peptide-therapeutic-immunogenicity-screening-program-301199121.html
https://www.prnewswire.com/news-releases/fda-awards-1-1m-contract-to-cubrc-and-epivax-for-validation-of-new-immunoinformatic-tool-for-prospective-immunogenicity-assessment-of-peptide-drugs-and-their-impurities-301157255.html
Market Place
Share 
